Sequential doxorubicin and docetaxel as first-line treatment in metastatic breast cancer: A GEICAM-9801 phase II study

  1. Alba, E. 11
  2. Ribelles, N. 1
  3. Antón, A. 2
  4. Pérez-Carrión, R. 3
  5. López-Vega, J.M. 4
  6. Llanos, M. 5
  7. Pelegri, A. 6
  8. Florián, J. 7
  9. Menéndez, M. 8
  10. Godes, M.J. 9
  1. 1 Hospital Regional Universitario de Málaga
    info

    Hospital Regional Universitario de Málaga

    Málaga, España

    ROR https://ror.org/01mqsmm97

  2. 2 Hospital Miguel Servet
    info

    Hospital Miguel Servet

    Zaragoza, España

    ROR https://ror.org/01r13mt55

  3. 3 Hospital Universitario de la Princesa
    info

    Hospital Universitario de la Princesa

    Madrid, España

    ROR https://ror.org/03cg5md32

  4. 4 Hospital Universitario Marqués de Valdecilla
    info

    Hospital Universitario Marqués de Valdecilla

    Santander, España

    ROR https://ror.org/01w4yqf75

  5. 5 Hospital Universitario de Canarias
    info

    Hospital Universitario de Canarias

    San Cristóbal de La Laguna, España

    ROR https://ror.org/05qndj312

  6. 6 Hospital Universitari Sant Joan de Reus
    info

    Hospital Universitari Sant Joan de Reus

    Reus, España

    ROR https://ror.org/04f7pyb58

  7. 7 Hospital Barbastro
  8. 8 C Hospitalario de Santiago
  9. 9 Hospital General Universitario de Valencia
    info

    Hospital General Universitario de Valencia

    Valencia, España

    ROR https://ror.org/03sz8rb35

Journal:
Breast Cancer Research and Treatment

ISSN: 0167-6806

Year of publication: 2003

Volume: 77

Issue: 1

Pages: 1-8

Type: Article

DOI: 10.1023/A:1021158711030 PMID: 12602899 SCOPUS: 2-s2.0-12244302218 GOOGLE SCHOLAR
Data source: Scopus